Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention
Status: | Completed |
---|---|
Conditions: | Neurology |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 18 - 80 |
Updated: | 4/2/2016 |
Start Date: | November 2011 |
End Date: | February 2014 |
Contact: | Tareq Kass-Hout, MD |
Email: | kasshouttareq@gmail.com |
Phone: | 716-887-5548 |
Wake up Symptomatic Stroke in Acute Brain Ischemia (WASSABI) Trial
The purpose of the trial is to study the safety and the effectiveness of using CT Perfusion
studies as an indicator to treat stroke patients with unknown time of onset.
studies as an indicator to treat stroke patients with unknown time of onset.
Inclusion Criteria:
Inclusion Criteria: To be eligible for entry into this study, candidates must meet all of
the following eligibility criteria at the time of Emergency Department presentation:
1. Age: 18-80 years old
2. Ischemic Wake Up Stroke (Unknown time of onset but less than 24 hours since last seen
normal)
3. National Institute of Health Stroke Scale (NIHSS) 8-22
4. Evidence of penumbra on Computed Tomography Perfusion(CTP) as mentioned above
5. Alberta Stroke Program Early Computed Tomography (CT) Score (ASPECTS 7 or more)
6. Signed informed consent
Exclusion Criteria:
Exclusion Criteria: Potential study patients will be excluded from study entry if any of
the following exclusion criteria exist at the time of screening:
1. Evidence of intracranial hemorrhage (Intracerebral hematoma, intraventricular
hemorrhage, subarachnoid hemorrhage (SAH), epidural hemorrhage, acute or chronic
subdural hematoma (SDH)) on the baseline CT
2. Historical Modified Rankin Scale (mRS) of ≥2
3. National Institute of Health Stroke Scale (NIHSS)<8 at the time of treatment
4. Positive pregnancy test in women at age of childbearing
5. Intracranial or intraspinal surgery within 3 months
6. Stroke or serious head injury within 3 months
7. History of intracranial hemorrhage
8. Uncontrolled hypertension at time of treatment (eg, >185 mm Hg systolic or >110 mm Hg
diastolic)
9. Seizure at the onset of stroke
10. Active internal bleeding
11. Intracranial neoplasm
12. Arteriovenous malformation or aneurysm
13. Clinical presentation suggesting post-MI pericarditis
14. Known bleeding diathesis including but not limited to current use of oral
anticoagulants producing an Internation normalized ratio (INR) >1.7
15. Internation normalized ratio (INR) >1.7
16. Administration of heparin within 48 hours preceding the onset of stroke with an
elevated activated Partial Thromboplastin Time(aPTT) at presentation
17. Platelet count <100,000/mm
18. Major surgery within 2 weeks
19. GastroIntestinal (GI) or urinary tract hemorrhage within 3 weeks
20. Aggressive treatment required to lower blood pressure
21. Glucose level <50 or >400 mg/dL
22. Arterial puncture at a noncompressible site or lumbar puncture within 1 week
We found this trial at
1
site
Click here to add this to my saved trials